- ►annals.org [PDF] GW Petty, RD Brown Jr, JP Whisnant, JRD … - Annals of internal medicine, 1999 - Am Coll Physicians George W. Petty, MD; Robert D. Brown Jr., MD; Jack P. Whisnant, MD; JoRean D.
Sicks, MS; W. Michael O'Fallon, PhD; and David O. Wiebers, MD ... Background:
Complication rates of medical therapy for secondary stroke prevention ... Cited by 78 - Related articles - BL Direct - All 6 versions
B Bergamasco, P Benna, A Carolei, M Rasura, … - Functional neurology, 1997 - cat.inist.fr A randomized trial comparing ticlopidine hydrochloride with indobufen for
the prevention of stroke in high-risk patients(TISS study). ... Cited by 25 - Related articles - BL Direct - All 2 versions
[CITATION] The antiplatelet effects of ticlopidine and clopidrogel
A Dávalos, R Suñer - Revista de neurologia - ncbi.nlm.nih.gov INTRODUCTION: Treatment of acute strokes in a Stroke Unit reduces intrahospital
mortality and dependence by 29%. One year later this effect is still present. It
is not known whether the use of intermediate care in the so-called Acute ... Cited by 5 - Related articles - BL Direct
[CITATION] El objetivo del tratamiento en la enfermedad cerebro vascular aguda y los enfoques …
- ►nih.gov DA McMahan, DM Smith, MA Carey, XH Zhou - Journal of general internal medicine, 1998 - Springer OBJECTIVE: To determine the incidence of major hemor- rhage among outpatients
started on warfarin therapy after the recommendation in 1986 for
reduced-intensity anticoag- ulation therapy was made, and to identify ... Cited by 99 - Related articles - BL Direct - All 8 versions
A Evans, S Davis, C Kilpatrick, R Gerraty, D … - Journal of Clinical Neuroscience, 2002 - Elsevier Atrial fibrillation is a major risk factor for stroke. Anticoagulant therapy
reduces this risk but increases the risk of haemorrhage. We aimed to compare the
morbidity related to the treatment of atrial fibrillation with warfarin ... Cited by 20 - Related articles - BL Direct - All 4 versions
FD Cervantes, LJ Schneiderman - Archives of Internal Medicine, 1975 - archinte.highwire.org Anticoagulant therapy in the treatment of cerebral thromboembolism remains
contro- versial despite 20 years of statistical studies. Among the unresolved
questions are (1) the relative value of aspirin vs coumarin deriva- tives ... Cited by 22 - Related articles - All 2 versions
